Cigna Group Files 8-K with Financials and Exhibits

TL;DR

Cigna Group filed an 8-K on 3/19/25, mostly financials and exhibits. No major news.

AI Summary

On March 19, 2025, The Cigna Group filed an 8-K report. The filing primarily concerns financial statements and exhibits, with no specific material events or transactions detailed in the provided excerpt. The company, formerly known as Cigna Corp and Halfmoon Parent, Inc., is incorporated in Delaware and headquartered in Bloomfield, Connecticut.

Why It Matters

This filing indicates routine corporate reporting, providing updated financial information and exhibits for The Cigna Group to the SEC.

Risk Assessment

Risk Level: low — The filing appears to be routine and does not disclose any new material events, risks, or significant financial changes.

Key Numbers

• 001-38769 — SEC File Number (Identifies the company's filing with the SEC)
• 82-4991898 — IRS Employer Identification No. (Company's tax identification number)

Key Players & Entities

• The Cigna Group (company) — Registrant
• Cigna Corp (company) — Former company name
• Halfmoon Parent, Inc. (company) — Former company name
• Delaware (jurisdiction) — State of incorporation
• Bloomfield, Connecticut (location) — Principal executive offices
• March 19, 2025 (date) — Date of report

FAQ

From the Filing

0001140361-25-009365.txt : 20250319 0001140361-25-009365.hdr.sgml : 20250319 20250319082515 ACCESSION NUMBER: 0001140361-25-009365 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250319 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250319 DATE AS OF CHANGE: 20250319 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cigna Group CENTRAL INDEX KEY: 0001739940 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 824991898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38769 FILM NUMBER: 25750921 BUSINESS ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 BUSINESS PHONE: 8602266000 MAIL ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 FORMER COMPANY: FORMER CONFORMED NAME: Cigna Corp DATE OF NAME CHANGE: 20181221 FORMER COMPANY: FORMER CONFORMED NAME: Halfmoon Parent, Inc. DATE OF NAME CHANGE: 20180508 8-K 1 ef20045617_8k.htm 8-K false 0001739940 NYSE 0001739940 2025-03-19 2025-03-19 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K   CURRENT REPORT   Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported) March 19, 2025   The Cigna Group   (Exact name of registrant as specified in its charter)   Delaware 001-38769 82-4991898 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 900 Cottage Grove Road Bloomfield , Connecticut 06002 (Address of principal executive offices) (Zip Code) ( 860 ) 226-6000 Registrant’s telephone number, including area code   Not Applicable (Former name or former address, if changed since last report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, Par Value $0.01 CI New York Stock Exchange, Inc. Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).   Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 8.01 Other Events.   On March 19, 2025, The Cigna Group (“Cigna”) completed the previously announced sale of its Medicare Advantage, Cigna Supplemental Benefits, Medicare Part D and CareAllies businesses to Health Care Service Corporation.   A copy of the press release issued by Cigna in connection with the closing of the sale is attached as Exhibit 99.1 to this report and incorporated herein by reference.   Item 9.01 Financial Statements and Exhibits.   (d) Exhibits   Exhibit No.   Description of Exhibit 99.1   Press Release, issued March 19, 2025.       104   Cover Page Interactive Data File (embedded within the Inlin